Tomáš Holeček

Tomáš Holeček

Auto-generated profile, based on publicly available information

Tomáš Holeček

International Clinical Research Center, St. Anne's University Hospital, Pekarska 53, 602 00, Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2016 in BioResources
Verified
Journal Article
Open access
PDF file
EOEliška Oberhofnerová
Eliška Oberhofnerová
KAKarolina Arnetová
Karolina Arnetová
THTomáš Holeček
Tomáš Holeček
Vlastimil BorůvkaVlastimil Borůvka
Vlastimil Borůvka
JBJan Bomba
Jan Bomba
Determination of Correlation between Destructive and Nondestructive Test Methods Applied on Modified Wood Exposed to Natural Weathering

19 March 2025 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
MMMary Luz Mojica-Pisciotti
Mary Luz Mojica-Pisciotti
THTomáš Holeček
Tomáš Holeček
VFVěra Feitová
Věra Feitová
LOLukáš Opatřil
Lukáš Opatřil
RPRoman Panovský
Roman Panovský
Background: Duchenne muscular dystrophy (DMD) patients are monitored periodically for cardiac involvement, including cardiac MRI with gadolinium-based contrast agents (GBCA). Texture analysis (TA) offers an alternative approach to assess late gadolinium enhancement (LGE) without relying on GBCA administration, impacting DMD patients’ care. The study aimed to evaluate the prognostic value of selected TA features in the LGE assessment of DMD patients. Results: We developed a pipeline to extract TA features of native T1 parametric mapping and evaluated their prognostic value in assessing LGE in DMD patients. For this evaluation, five independent TA features were selected using Boruta to identify relevant features based on their importance, least absolute shrinkage and selection operator (LASSO) to reduce the number of features, and hierarchical clustering to target multicollinearity and identify independent features. Afterward, logistic regression was used to determine the features with better discrimination ability. The independent feature inverse difference moment normalized (IDMN), which measures the pixel values homogeneity in the myocardium, achieved the highest accuracy in classifying LGE (0.857 (0.572–0.982)) and also was significantly associated with changes in the likelihood of LGE in a subgroup of patients with three yearly examinations (estimate: 23.35 (8.7), p-value = 0.008). Data are presented as mean (SD) or median (IQR) for normally and non-normally distributed continuous variables and numbers (percentages) for categorical ones. Variables were compared with the Welch t-test, Wilcoxon rank-sum, and Chi-square tests. A P-value < 0.05 was considered statistically significant. Conclusion: IDMN leverages the information native T1 parametric mapping provides, as it can detect changes in the pixel values of LGE images of DMD patients that may reflect myocardial alterations, serving as a supporting tool to reduce GBCA use in their cardiac MRI examinations.

19 October 2023 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
LMLucia Masárová
Lucia Masárová
RPRoman Panovský
Roman Panovský
MPMartin Pesl
Martin Pesl
LMLuz Mojica-Pisciotti Mary
Luz Mojica-Pisciotti Mary
THTomáš Holeček
Tomáš Holeček
VFVěra Feitová
Věra Feitová

21 October 2022 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
MMMary Luz Mojica-Pisciotti
Mary Luz Mojica-Pisciotti
RPRoman Panovský
Roman Panovský
THTomáš Holeček
Tomáš Holeček
LOLukáš Opatřil
Lukáš Opatřil
On March 11, 2020, the World Health Organization raised the coronavirus disease 2019 (COVID-19) status to a pandemic level. The disease caused a global outbreak with devastating consequences, and a fair percentage of patients who have recovered from it continue experiencing persistent sequelae. Hence, identifying the medium and long-term effects of the COVID-19 disease is crucial for its future management. In particular, cardiac complications, from affected function to myocardial injuries, have been reported in these patients. Considering that cardiovascular magnetic resonance (CMR) imaging is the gold standard in diagnosing myocardial involvement and has more advantages than other medical imaging modalities, assessing the outcomes of patients who recovered from COVID-19 with CMR could prove beneficial. This review compiles common findings in CMR in patients from the general population who recovered from COVID-19. The CMR-based techniques comprised parametric mapping for analyzing myocardial composition, feature tracking for studying regional heart deformation, and late gadolinium enhancement for detecting compromised areas in the cardiac muscle. A total of 19 studies were included. The evidence suggests that it is more likely to find signs of myocardial injury in patients who recovered from COVID-19 than in healthy controls, including changes in T1 and T2 mapping relaxation times, affected strain, or the presence of late gadolinium enhancement (LGE) lesions. However, more than two years after the outbreak, there is still a lack of consensus about how these parameters may indicate cardiac involvement in patients who recovered from the disease, as limited and contradictory data is available.

24 August 2026 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
MMMary Luz Mojica-Pisciotti
Mary Luz Mojica-Pisciotti
RPRoman Panovský
Roman Panovský
THTomáš Holeček
Tomáš Holeček
VFVěra Feitová
Věra Feitová
LOLukáš OpatřIl
Lukáš OpatřIl
TKTomas Kepak
Tomas Kepak

15 July 2026 in BMC Medical Imaging
Verified
Journal Article
Open access
LOLukáš OpatřIl
Lukáš OpatřIl
MMMary Luz Mojica-Pisciotti
Mary Luz Mojica-Pisciotti
RPRoman Panovský
Roman Panovský
JMJan Machal
Jan Machal
THTomáš Holeček
Tomáš Holeček
JKJan Krejčí
Jan Krejčí
Recent-onset dilated cardiomyopathy (RODCM), defined as new DCM with heart failure (HF) symptoms appearing within six months, is a less documented form of HF. This study aims to evaluate pulmonary circulation imaging biomarkers (PCIB) obtained by cardiovascular magnetic resonance (CMR) in patients with RODCM to assess their association with pulmonary hypertension, systolic and diastolic function, and clinical improvement. Ninety RODCM patients with baseline and one-year follow-up CMR, clinical examination, and transthoracic echocardiography were retrospectively included. Twenty-six were excluded following a myocarditis diagnosis confirmed by endomyocardial biopsy (EMB). PCIB (pulmonary transit time (PTT), corrected PTT (PTTc), pulmonary transit beats (PTB), and pulmonary blood volume index (PBVI)) were assessed using a first-pass perfusion CMR sequence. Pulmonary hypertension, diastolic, and systolic function were assessed. Correlations between PCIB and echocardiographic changes were analyzed. Patients were classified as responders/non-responders based on left ventricular ejection fraction (LVEF) improvement. From baseline to follow-up, LVEF increased (25% to 40%), while EDD (65 mm to 61 mm), sPAP (24.2 mmHg to 20.0 mmHg), and E/e' ratio (13 to 9) significantly reduced. Thirty-three patients were labeled as responders. PTT, PTTc, and PTB correlated with ΔE/e', diastolic function improvement, and ΔsPAP. PBVI correlated with ΔsPAP. PTB correlated with ΔNYHA class. The PCIB could not predict whether a patient would be a responder. This study focused on PCIB as outcome predictors in patients with RODCM with EMB-excluded myocarditis. Our findings show that PTB and PTTc correlated with ΔE/e', diastolic function improvement, and ΔsPAP, while PTB additionally correlated with ΔNYHA class.